Skip to content

With an Eye on the Future, Biolog Launches Odin

Biolog, Inc. 2 mins read

HAYWARD, CA / ACCESSWIRE / June 15, 2023 / Biolog, Inc., a leading provider of microbial polyphasic analysis, today announced the launch of the Odin™ system, an all-in-one cellular phenotyping and microbial identification platform. Odin is compatible with all Biolog assays and is available now.

Until today, Biolog's OmniLog® platform was the gold standard for researchers who want actionable insights on microbial metabolic phenotypes. Odin now builds on that foundation while maintaining the core capabilities to incubate, analyze, and compare thousands of microbial and mammalian growth conditions in a single experiment, and to identify aerobic bacteria by its metabolic fingerprint.

Odin changes up the detection method and uses Optical Density (OD), which enables a critical additional modality to measure cell growth. Now on a single platform, researchers can distinguish the effect of a substrate on growth (by OD) and by respiration using our proprietary dye, now an absorbance-based measurement. With the additional Odin capabilities, researchers can now decouple a microbe's respiration rate from its division rate and more fully understand the metabolic output of a cell. With a fully loaded system, Odin records the OD for all conditions for up to 50 plates at a time, measuring the kinetics of cell growth and respiration for thousands of conditions in parallel.

Odin also has broader identification capabilities, including anaerobes, yeast, and filamentous fungi. All told, Odin can identify thousands of microbes, allowing researchers to classify unknown organisms and phenotype them on the same platform.

"We heard from our customers the need to directly measure growth. In a short time, we brought in additional scientific expertise, and built a product development engine. The customer-focused mindset and our dedicated teams have enabled us to quickly meet the needs of our customers," said Robert Wicke, CEO of Biolog.

"Understanding how microbes respond to their environment and food sources is the major economic driver in sustainable agriculture, bioprocessing and synthetic biology, to name just a few areas. We are enthusiastic about the foundation that Odin creates for Biolog and our customers," said Mr. Wicke.

About Biolog

Biolog has the tools, services, and support to provide the microbial phenotypic characterization and polyphasic identification capabilities required to produce functionally relevant insights. Our products and services enable characterization of microbial and mammalian cells as well as identification of thousands of species of bacteria, yeast, and fungi. Learn more at

Contact Information:

John Proctor, Ph.D.

SOURCE: Biolog Inc.


View source version on

More from this category

  • Biotechnology
  • 07/06/2024
  • 06:00
Centre for Eye Research Australia. Bionics Institute. Bionic Vision Technologies

Bionic eye trial reveals substantial vision improvements over two and a half years

Results of the first clinical trial of Australia’s ‘second generation’ bionic eye have demonstrated ‘substantial improvement’ in four participants’ functional vision, daily activities and quality of life over a period of more than two and a half years. Detailed outcomes from the trial, led by the Centre for Eye Research Australia, Bionics Institute, University of Melbourne and Royal Victorian Eye and Ear Hospital, are published in Ophthalmology Science. The findings add to interim results which showed that the second-generation bionic eye developed by Australian company Bionic Vision Technologies provided rapid improvements for four patients with blindness caused the genetic eye…

  • Biotechnology, Results Statistics
  • 31/05/2024
  • 07:54
The Lottery Corporation Ltd

Powerball Draw no. 1463

Official Results Powerball Draw no. 1463 Draw Date: Thursday, 30 May 2024 Drawn Numbers Winning Numbers 35 2 3 33 20 22 10 (drawn order) Powerball 9 Dividends Dividends Total Winners Total Prizes Payable Division 1 $0.00 0 $0.00 Division 2 $270,217.65 1 $270,217.65 Division 3 $9,598.45 35 $335,945.75 Division 4 $571.70 511 $292,138.70 Division 5 $192.00 1,141 $219,072.00 Division 6 $79.50 17,268 $1,372,806.00 Division 7 $49.50 21,547 $1,066,576.50 Division 8 $20.30 111,436 $2,262,150.80 Division 9 $11.90 326,742 $3,888,229.80 478,681 $9,707,137.20 Division 1 Jackpots to $12,000,000.00

  • Contains:
  • Biotechnology
  • 30/05/2024
  • 20:07
Moolec Science SA

Moolec Science Presents Third Quarter Fiscal Year 2024 Business Update

LUXEMBOURG / ACCESSWIRE / May 30, 2024 / Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today its Business Update for the third quarter of Fiscal Year 2024 ended March 31, 2024.Moolec Science Logo The main highlights of Moolec's business update are as follows:Piggy Sooy™ Product | Soybean Platform: Moolec's patented soybean product received USDA-APHIS Regulatory Status Review approval in April 2024.Safflower Platform: GLASO™ planting campaign progressing as expected. Two US Patents granted for production of chymosin in safflower seeds (SPC2) extended exclusive technology protection until 2041.Financial…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.